• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导型一氧化氮合酶(iNOS)mRNA在致死性和非致死性鼠疟原虫株靶器官中的表达

Expression of inducible nitric oxide synthase (iNOS) mRNA in target organs of lethal and non-lethal strains of murine malaria.

作者信息

Nahrevanian Hossein, Dascombe Michael J

机构信息

School of Biological Sciences, The University of Manchester, UK.

出版信息

Parasite Immunol. 2002 Sep-Oct;24(9-10):471-8. doi: 10.1046/j.1365-3024.2002.00490.x.

DOI:10.1046/j.1365-3024.2002.00490.x
PMID:12654089
Abstract

Nitric oxide (NO) is a putative mediator of the immunological and/or pathological responses to malaria, consequently it is a potential target for novel drug therapy. Numerous cell types increase expression of inducible nitric oxide synthase (iNOS) under inflammatory conditions, the most relevant stimuli being cytokines and endotoxins. In this study the expression of iNOS mRNA in several target organs (brain, liver, spleen) of malaria have been investigated in MF1 mice during lethal Plasmodium (P.) berghei and non-lethal P. c. chabaudi infection. In P. berghei malaria, iNOS mRNA decreased in liver and was unchanged in spleen during the period of rising parasitaemia, but increased in both organs late in the infection, when parasitaemia was high and death imminent. In mice infected with P. c. chabaudi, spleen iNOS mRNA increased progressively throughout the early, peak and recovery periods of parasitaemia, but decreased in liver. Brain iNOS mRNA decreased in samples collected throughout the time courses of both infections. Hence it is evident that changes in iNOS mRNA in murine malaria depend upon the tissue, day of infection, degree of parasitaemia and strain of Plasmodium. These data indicate induction of iNOS mRNA in the spleen has a role in combating these strains of Plasmodium in MF1 mice. Failure to clear lethal P. berghei parasitaemia was associated with increased iNOS mRNA expression in the liver, which may contribute to the pathology of this malaria.

摘要

一氧化氮(NO)被认为是疟疾免疫和/或病理反应的介质,因此它是新型药物治疗的潜在靶点。在炎症条件下,许多细胞类型会增加诱导型一氧化氮合酶(iNOS)的表达,最相关的刺激因素是细胞因子和内毒素。在本研究中,研究了致死性伯氏疟原虫和非致死性约氏疟原虫感染期间,MF1小鼠疟疾的几个靶器官(脑、肝、脾)中iNOS mRNA的表达。在伯氏疟原虫疟疾中,在寄生虫血症上升期间,肝脏中的iNOS mRNA减少,脾脏中的iNOS mRNA无变化,但在感染后期,当寄生虫血症很高且即将死亡时,两个器官中的iNOS mRNA均增加。在感染约氏疟原虫的小鼠中,脾脏iNOS mRNA在寄生虫血症的早期、高峰期和恢复期逐渐增加,但在肝脏中减少。在两种感染的整个病程中采集的样本中,脑iNOS mRNA均减少。因此,很明显,小鼠疟疾中iNOS mRNA的变化取决于组织、感染天数、寄生虫血症程度和疟原虫菌株。这些数据表明,脾脏中iNOS mRNA的诱导在MF1小鼠对抗这些疟原虫菌株中起作用。未能清除致死性伯氏疟原虫的寄生虫血症与肝脏中iNOS mRNA表达增加有关,这可能导致这种疟疾的病理变化。

相似文献

1
Expression of inducible nitric oxide synthase (iNOS) mRNA in target organs of lethal and non-lethal strains of murine malaria.诱导型一氧化氮合酶(iNOS)mRNA在致死性和非致死性鼠疟原虫株靶器官中的表达
Parasite Immunol. 2002 Sep-Oct;24(9-10):471-8. doi: 10.1046/j.1365-3024.2002.00490.x.
2
Up- and down-modulation of liver cytochrome P450 activities and associated events in two murine malaria models.两种鼠疟模型中肝细胞色素 P450 活性的上调和下调及其相关事件。
Malar J. 2010 Mar 22;9:81. doi: 10.1186/1475-2875-9-81.
3
Nitric oxide and reactive nitrogen intermediates during lethal and nonlethal strains of murine malaria.致死性和非致死性鼠疟原虫株中的一氧化氮和活性氮中间体
Parasite Immunol. 2001 Sep;23(9):491-501. doi: 10.1046/j.1365-3024.2001.00406.x.
4
The role of nitric oxide and its up/downstream molecules in malaria: cytotoxic or preventive?一氧化氮及其上下游分子在疟疾中的作用:细胞毒性还是预防性?
Southeast Asian J Trop Med Public Health. 2003;34 Suppl 2:44-50.
5
Mice lacking inducible nitric oxide synthase develop exacerbated hepatic inflammatory responses induced by Plasmodium berghei NK65 infection.缺乏诱导型一氧化氮合酶的小鼠在感染疟原虫 NK65 后会发展出更严重的肝脏炎症反应。
Microbes Infect. 2013 Nov;15(13):903-10. doi: 10.1016/j.micinf.2013.08.001. Epub 2013 Aug 27.
6
Gamma interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical.γ干扰素的产生对于针对血液期伯氏疟原虫XAT感染的保护性免疫至关重要,但一氧化氮的产生和自然杀伤细胞的激活均不重要。
Infect Immun. 1999 May;67(5):2349-56. doi: 10.1128/IAI.67.5.2349-2356.1999.
7
Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice.一氧化氮在小鼠脾脏而非肝脏中的表达与对血液期疟疾的抗性相关。
J Immunol. 1995 Dec 1;155(11):5306-13.
8
Trichinella spiralis co-infection exacerbates Plasmodium berghei malaria-induced hepatopathy.旋毛虫合并感染加剧伯氏疟原虫疟疾诱导的肝损伤。
Parasit Vectors. 2020 Sep 3;13(1):440. doi: 10.1186/s13071-020-04309-6.
9
Differential induction of malaria liver pathology in mice infected with Plasmodium chabaudi AS or Plasmodium berghei NK65.疟原虫 chabaudi AS 或疟原虫 berghei NK65 感染小鼠肝病理的差异诱导。
Malar J. 2018 Jan 9;17(1):18. doi: 10.1186/s12936-017-2159-3.
10
Parasite killing in murine malaria does not require nitric oxide production.鼠疟中的寄生虫杀伤并不需要一氧化氮的产生。
Parasitology. 1999 Feb;118 ( Pt 2):139-43. doi: 10.1017/s0031182098003618.

引用本文的文献

1
iNOS polymorphism modulates iNOS/NO expression via impaired antioxidant and ROS content in P. vivax and P. falciparum infection.iNOS 多态性通过影响疟原虫感染中的抗氧化和 ROS 含量来调节 iNOS/NO 的表达。
Redox Biol. 2018 May;15:192-206. doi: 10.1016/j.redox.2017.12.005. Epub 2017 Dec 14.
2
Supplementation with Abscisic Acid Reduces Malaria Disease Severity and Parasite Transmission.补充脱落酸可降低疟疾疾病严重程度和寄生虫传播。
Am J Trop Med Hyg. 2016 Jun 1;94(6):1266-75. doi: 10.4269/ajtmh.15-0904. Epub 2016 Mar 21.
3
In Vivo Antimalarial Effects of Iranian Flora Artemisia khorassanica against Plasmodium berghei and Pharmacochemistry of its Natural Components.
伊朗植物蒿属植物霍拉桑蒿对伯氏疟原虫的体内抗疟作用及其天然成分的药物化学研究
Iran J Parasitol. 2010 Mar;5(1):6-19.
4
Hypothesis links emergence of chloroquine-resistant malaria and other intracellular pathogens and suggests a new strategy for treatment of diseases caused by intracellular parasites.假说将耐氯喹疟疾及其他细胞内病原体的出现联系起来,并提出了一种治疗由细胞内寄生虫引起疾病的新策略。
Med Hypotheses. 2004;62(3):354-7. doi: 10.1016/j.mehy.2003.12.004.